- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
< Back to Bio
Mark Sentenac
Mark Sentenac
News 5 results
In the News · Source: Law360
December 22, 2023
Mark Sentenac, Micha Gallo and Simran Modi’s article, “Mitigating Risks of Developing Drugs and Devices With AI” is named a Law360 top guest article of 2023
In the News · Source: Pennsylvania Record
In the News · Source: The Legal Intelligencer
July 15, 2022
Mark Sentenac, Susan Clare and Ryan Kearney advise AbbVie and Allergan in a product liability dispute
In the News · Source: Law360, Global Competition Review, Bloomberg Law, New York Law Journal, Law.com International, Global Arbitration Review, Daily Journal, The Deal, Intellectual Property Magazine, World Trademark Review, Commercial Dispute Resolution, Global Investigations Review, Le Monde du Droit, La Lettre des Juristes d’Affaires, Daily Report, The Oath, Houston Business Journal, The Texas Lawbook and Chicago Daily Bulletin
December 3, 2021
K&S elects 32 new partners and promotes 16 counsel across 16 cities
Press Release
December 2, 2021
King & Spalding Promotes 32 New Partners and 16 Counsel Across 16 Cities